These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The use of MRI as an outcome measure in clinical trials. Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836 [TBL] [Abstract][Full Text] [Related]
5. Defining the response to multiple sclerosis treatment: the role of conventional magnetic resonance imaging. Rovaris M; Filippi M Neurol Sci; 2005 Dec; 26 Suppl 4():S204-8. PubMed ID: 16388359 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study. Chiu AW; Richert N; Ehrmantraut M; Ohayon J; Gupta S; Bomboi G; Gaindh D; Cantor FK; Frank JA; McFarland HF; Bagnato F Arch Neurol; 2009 Jan; 66(1):39-43. PubMed ID: 19001157 [TBL] [Abstract][Full Text] [Related]
8. The role of MRS and fMRI in multiple sclerosis. Tartaglia MC; Arnold DL Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835 [TBL] [Abstract][Full Text] [Related]
9. The use of glatiramer acetate in the treatment of multiple sclerosis. Wolinsky JS Adv Neurol; 2006; 98():273-92. PubMed ID: 16400839 [TBL] [Abstract][Full Text] [Related]
14. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller DH; Montalban X; Polman C; Rocca MA; Thompson AJ; Yousry TA; Filippi M Neurology; 2009 May; 72(19):1693-701. PubMed ID: 19433744 [TBL] [Abstract][Full Text] [Related]
15. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Minneboo A; Uitdehaag BM; Ader HJ; Barkhof F; Polman CH; Castelijns JA Neurology; 2005 Jul; 65(1):56-61. PubMed ID: 16009885 [TBL] [Abstract][Full Text] [Related]
16. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis. Filippi M; Rocca MA Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834 [No Abstract] [Full Text] [Related]
17. The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials. Martinelli Boneschi F; Rovaris M; Comi G; Filippi M Mult Scler; 2004 Aug; 10(4):341-7. PubMed ID: 15327027 [TBL] [Abstract][Full Text] [Related]
18. MRI as a marker for disease heterogeneity in multiple sclerosis. Bielekova B; Kadom N; Fisher E; Jeffries N; Ohayon J; Richert N; Howard T; Bash CN; Frank JA; Stone L; Martin R; Cutter G; McFarland HF Neurology; 2005 Oct; 65(7):1071-6. PubMed ID: 16217061 [TBL] [Abstract][Full Text] [Related]
19. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781 [No Abstract] [Full Text] [Related]